Rayburn West Financial Services LLC opened a new stake in International Business Machines Corporation [NYSE: IBM] during the fourth quarter of 2025, acquiring 14,591 shares valued at approximately $4.32 million, according to its most recent Form 13F filing with the Securities and Exchange Commission.

IBM now represents 2.7% of Rayburn West’s total investment portfolio and is the firm’s eighth-largest holding, indicating a meaningful allocation to a stock that has been navigating a significant pullback from its 52-week high of $324.90 while still generating strong fundamental results.

The firm also opened several other new positions in the same reporting period, including 3,501 shares in Accenture PLC [NYSE: ACN] valued at approximately $939,000, 16,391 shares in Walmart Inc. [NASDAQ: WMT] worth around $1.83 million, and 17,848 shares in PNC Financial Services Group [NYSE: PNC] valued at approximately $3.73 million.

IBM’s most recent quarterly earnings report, released on April 22, demonstrated continued business momentum with first-quarter EPS of $1.91, beating the consensus estimate of $1.81 by $0.10, and revenue of $15.92 billion that was 9.5% higher year-over-year and exceeded analyst expectations of $15.60 billion.

The company also announced a quarterly dividend increase to $1.69 per share, implying a 3.1% annualised dividend yield at current prices, and continued expanding its AI and hybrid cloud portfolio with new Red Hat AI Inference and Red Hat OpenShift Virtualization services announced in the days following the Rayburn West disclosure.

Jefferies analysts described IBM as well-positioned to benefit from enterprise AI demand in a recent research note, citing software pipeline strength and cross-selling opportunities around its watsonx platform as key drivers, while several other research firms framed the stock as attractive for investors seeking exposure to AI within a more established and conservatively valued technology company.

At $215.05 as of May 14, IBM trades near its 52-week low of $212.34, significantly below both its 50-day moving average of $241.64 and its 200-day moving average of $276.07, reflecting a period of sustained price weakness driven partly by concerns about AI replacing some IBM software workloads.

Despite recent analyst price target cuts from Oppenheimer, which reduced its target from $380 to $320 while maintaining an Outperform rating, and from JPMorgan which set a Neutral rating with a $283 target, the Wall Street consensus remains at Moderate Buy, with twelve Buy ratings, seven Hold ratings, one Strong Buy, and a consensus price target of $294.41.

Institutional investors and hedge funds collectively own 58.96% of IBM’s outstanding shares, and Virginia Retirement Systems ET Al notably grew its IBM stake by 424.6% in Q4 2025, acquiring an additional 211,040 shares for a total position of 260,740 shares worth approximately $77.2 million.